Model Number 200 |
Device Problems
Calcified (1077); Gradient Increase (1270); Device Operates Differently Than Expected (2913)
|
Patient Problems
Pulmonary Regurgitation (2023); Pulmonary Valve Stenosis (2024); Cusp Tear (2656)
|
Event Date 12/30/2013 |
Event Type
Injury
|
Manufacturer Narrative
|
The device history record was reviewed and showed that this product met all manufacturing specifications for product released for distribution.No issues were identified that would have impacted this event.At this time, a conclusion to the reported endocarditis three yrs post implant is not determined.Endocarditis that occurs more than 12 month after the procedure are called late prosthetic-valve endocarditis and are largely community-acquired versus a result of the manufacturing process of the valve.It is possible that the reported endocarditis contributed to the clinical observations 5 yrs post implant.The device was explanted and another contegra was implanted.The device was not returned for analysis.(b)(6).
|
|
Event Description
|
Medtronic received information that five years post implant of the pulmonary valved conduit was explanted due to stenosis, calcification, cuspal tears, and central regurgitation with a peak gradient of 59mmhg and a mean gradient of 32mmhg.Operative notes indicated patient with a history of possible endocarditis three years post implant.The conduit was removed in pieces and will not be returned.Another contegra was implanted.No further adverse patient effects were reported.
|
|
Manufacturer Narrative
|
Product analysis: without the return of the product, no definitive conclusion can be made regarding the clinical observation.Conclusion: the device history record review is in process, once the review is complete a supplemental report will be submitted.(b)(4).(b)(6).
|
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|